1. Home
  2. MIST vs AUBN Comparison

MIST vs AUBN Comparison

Compare MIST & AUBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • AUBN
  • Stock Information
  • Founded
  • MIST 2003
  • AUBN 1907
  • Country
  • MIST Canada
  • AUBN United States
  • Employees
  • MIST N/A
  • AUBN N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • AUBN Major Banks
  • Sector
  • MIST Health Care
  • AUBN Finance
  • Exchange
  • MIST Nasdaq
  • AUBN Nasdaq
  • Market Cap
  • MIST 89.8M
  • AUBN 75.8M
  • IPO Year
  • MIST N/A
  • AUBN 1995
  • Fundamental
  • Price
  • MIST $1.60
  • AUBN $24.82
  • Analyst Decision
  • MIST Strong Buy
  • AUBN
  • Analyst Count
  • MIST 2
  • AUBN 0
  • Target Price
  • MIST $7.50
  • AUBN N/A
  • AVG Volume (30 Days)
  • MIST 1.8M
  • AUBN 1.7K
  • Earning Date
  • MIST 08-07-2025
  • AUBN 07-22-2025
  • Dividend Yield
  • MIST N/A
  • AUBN 4.35%
  • EPS Growth
  • MIST N/A
  • AUBN 717.98
  • EPS
  • MIST N/A
  • AUBN 1.88
  • Revenue
  • MIST N/A
  • AUBN $31,155,000.00
  • Revenue This Year
  • MIST N/A
  • AUBN N/A
  • Revenue Next Year
  • MIST N/A
  • AUBN N/A
  • P/E Ratio
  • MIST N/A
  • AUBN $13.23
  • Revenue Growth
  • MIST N/A
  • AUBN 38.25
  • 52 Week Low
  • MIST $0.63
  • AUBN $16.75
  • 52 Week High
  • MIST $2.75
  • AUBN $27.63
  • Technical
  • Relative Strength Index (RSI)
  • MIST 83.15
  • AUBN 59.12
  • Support Level
  • MIST $1.86
  • AUBN $23.13
  • Resistance Level
  • MIST $1.97
  • AUBN $25.00
  • Average True Range (ATR)
  • MIST 0.14
  • AUBN 0.90
  • MACD
  • MIST 0.06
  • AUBN -0.01
  • Stochastic Oscillator
  • MIST 100.00
  • AUBN 43.89

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About AUBN Auburn National Bancorporation Inc.

Auburn National Bancorp Inc operates as a bank holding company, which offers checking, savings, transaction deposit accounts and certificates of deposit, and is an active residential mortgage lender in its primary service area. The Bank's primary service area includes the cities of Auburn and Opelika, Alabama and nearby surrounding areas in East Alabama, predominantly in Lee County. The Bank also offers commercial, financial, agricultural, real estate construction and consumer loan products and other financial services. The Bank also provides automated teller machine (ATM) services in East Alabama and operates ATM machines. The Bank offers Visa Checkcards, which are debit cards. The Bank offers online banking, bill payment and other electronic banking services through its Internet website.

Share on Social Networks: